✦ LIBER ✦

PND8 COST-EFFECTIVENESS ANALYSIS OF REBIF IN FIRST-LINE RELAPSING REMITTING MULTIPLE SCLEROSIS IN GERMANY

✍ Scribed by MJ Nuijten; T Mittendorf; A Jäcker; U Osowski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND28 Cost-Effectiveness Analysis of Int

✍ R. Sánchez-de la Rosa; E. Sabater; M.A. Casado 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PND11 Budget Impact Analysis of First-Li

✍ R. Sánchez-de la Rosa; E. Sabater; M.A. Casado 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PND8 COST-EFFECTIVENESS AND BUDGET IMPAC

✍ O Espallardo; C Crespo; C Polanco; D Nieves 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

PND19 A LONG-TERM COST-EFFECTIVENESS MAR

✍ C Plesnila-Frank; N Putzki; D Eheberg; V Limmroth; Z Katsarava; SN Patel 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PND9 THE COST-EFFECTIVENESS OF NATALIZUM

✍ K Meyer; E Chiao 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PND35 Belgian Cost-Utility Analysis of G

✍ S. Drieskens; K. Moeremans 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB